Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Cancer Prev Res (Phila). 2019 Nov 7;13(2):185–194. doi: 10.1158/1940-6207.CAPR-19-0265

Figure 2.

Figure 2.

Bisphosphonates and metformin synergized to inhibit colonic AdCa multiplicity and incidence. Comparison of the colonic AdCa multiplicity and incidence between control and experimental groups. Bisphosphonates alone cause non-significant inhibition of the colonic AdCa multiplicity. Importantly, combination of bisphosphonates and metformin led to significant suppression of the colon AdCa multiplicity (A) and incidence (B).